The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats

Molecular and Cellular Biochemistry

Volumn 282, Issue 1-2, 2006, Pages 141-146

  Wu, Min ^a   Li, Yu Guang ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

Adhesion factor; Atherosclerosis; CD40; CD40L; Matrix metalloproteinase

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CHOLESTEROL; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD CELL; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NONHUMAN; PROTEIN LOCALIZATION; RAT; RAT STRAIN; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD40; AORTA; ATHEROSCLEROSIS; CD40 LIGAND; CHOLESTEROL; CHOLESTEROL, DIETARY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR;

ANIMALIA;

EID: 29644438767     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-1741-8     Document Type: Article

References (23)

1. Spronk HM, van der Voort D, Ten Cate H: Blood coagulation and the risk of atherothrombosis: A complex relationship. Thromb J 2: 12-12, 2004 15574198
2. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L: Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 95: 452-456, 2005 10.1016/ j.amjcard.2004.10.009
3. Dardik A, Yamashita A, Aziz F, Asada H, Sumpio BE: Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. J Vasc Surg 41: 321-331, 2005 15768016
4. Luedemann J, Schminke U, Berger K, Piek M, Willich SN, Doring A, John U, Kessler C: Association between behavior-dependent cardiovascular risk factors and asymptomatic carotid atherosclerosis in a general population. Stroke 33: 2929-2935, 2002 10.1161/01.STR.0000038422.57919.7F
5. Mullenix PS, Andersen CA, Starnes BW: Atherosclerosis as inflammation. Ann Vasc Surg 19: 130-138, 2005 10.1007/s10016-004-0153-z
6. Jiang X, Zeng HS, Guo Y, Zhou ZB, Tang BS, Li FK: The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Chin Med J (Engl) 117: 1825-1829, 2004 1:CAS:528:DC%2BD2MXhtVOntb8%3D
7. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA Jr, Flavell RA: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273: 1864-1867, 1996 8791592
8. Mott JD, Werb Z: Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558-564, 2004 10.1016/ j.ceb.2004.07.010
9. Randeva HS, Lewandowski, KC, Komorowski J, Murray RD, O'Callaghan CJ, Hillhouse EW, Stepien H, Shalet SM: Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals. Circulation 109: 2405-2410, 2004 10.1161/01.CIR.0000129763.51060.77
10. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94: 1931-1936, 1997 10.1073/pnas.94.5.1931
11. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Specchia G: Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88: 358-363, 1993 8101771
12. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR: Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79: 1828-1835, 1999 10.1038/sj.bjc.6690291
13. French LE, Huard B, Wysocka M, Shane R, Contassot E, Arrighi JF, Piguet V, Calderara S, Rook AH: Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sezary syndrome: Circumvention by hexameric soluble CD40L. Blood 105: 219-225, 2005 10.1182/blood-2004-03-1055
14. Davies MJ: Reactive oxygen species, metalloproteinases, and plaque stability. Circulation 97: 2382-2383, 1998 9641687
15. Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P: Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: A role for CD40 signaling in plaque rupture? Circ Res 81: 448-454, 1997 9285647
16. Eckart RE, Uyehara CF, Shry EA, Furgerson JL, Krasuski RA: Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization. J Interv Cardiol 17: 27-31, 2004 10.1111/ j.1540-8183.2004.00289.x
17. Wang Y, Blessing F, Walli AK, Uberfuhr P, Fraunberger P, Seidel D: Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins - reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 175: 145-150, 2004 10.1016/j.atherosclerosis.2004.03.011
18. Libby P, Mach F, Schonbeck U, Bourcier T, Aikawa M: Regulation of the thrombotic potential of atheroma. Thromb Haemost 82: 736-741, 1999 10605776
19. Schonbeck U, Sukhova GK, Shimizu K, Mach F, Libby P: Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci USA 97: 7458-7463, 2000 10.1073/pnas.97.13.7458
20. Galang N, Sasaki H, Maulik N: Apoptotic cell death during ischemia/ reperfusion and its attenuation by antioxidant therapy. Toxicology 148: 111-18, 2000 10.1016/S0300-483X(00)00201-8
21. Ferroni P, Basili S, Martini F, Cardarello CM, Ceci F, Di Franco M, Bertazzoni G, Gazzaniga PP, Alessandri C: Serum metalloproteinase 9 levels in patients with coronary artery disease: A novel marker of inflammation. J Investig Med 51: 295-300, 2003 14577520
22. Schonbeck U, Mach F, Sukhova GK, Atkinson E, Levesque E, Herman M, Graber P, Basset P, Libby P: Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med 189: 843-853, 1999 10.1084/jem.189.5.843
23. Li D, Liu L, Chen H, Sawamura T, Mehta JL: LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23: 816-821, 2003 12637341